<DOC>
	<DOCNO>NCT02529865</DOCNO>
	<brief_summary>The purpose study evaluate efficacy safety periurethral injection autologous Adipose Derived Regenerative Cells ( ADRCs ) male stress urinary incontinence .</brief_summary>
	<brief_title>Clinical Trial Autologous Adipose Derived Regenerative Cells Treatment Male Stress Urinary Incontinence</brief_title>
	<detailed_description />
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<mesh_term>Urinary Incontinence , Stress</mesh_term>
	<criteria>Males stress urinary incontinence insufficient effect behavioral therapy pharmacotherapy persist 1 year either follow surgical procedure : Patients symptoms radical prostatectomy localized prostate cancer currently without relapse/metastasis , PSA level le 0.1 ng/mL 1 year Patients symptoms transurethral prostatectomy laser prostatectomy prostatic hyperplasia , PSA level le 4.0 ng/mL 1 year Age 20 Mild moderate urinary incontinence 24hour pad test Patients keep bladder diary satisfactory manner Patients willing able give sign consent Concurrent type urinary incontinence History urinary reproductive surgery within 6 month History behavioral therapy pharmacotherapy within 3 month Concurrent diabetes insipidus History radiotherapy lower urinary tract History ADRCs treatment stress urinary incontinence History type cell therapy within 6 month Participation clinical trial within 3 month Concurrent low urinary tract obstruction Concurrent urolithiasis , urinary tract infection interstitial cystitis History recurrent urinary tract infection History malignant neoplasm within 5 year suspicion Life expectancy less 1 year Any patient trial investigator deem ineligible study</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Cell Transplantation</keyword>
</DOC>